Emerging PEGylated drugs | 2009/05/20 | English | 191 |
What is the future of PEGylated therapies? | 2015/10/02 | English | 165 |
Emerging treatments for traumatic brain injury | 2009/02/27 | English | 147 |
Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis | 2009/02/27 | English | 138 |
Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity | 2008/06/01 | English | 135 |
Emerging anti-HIV drugs | 2005/05/01 | English | 117 |
Emerging treatments for noise-induced hearing loss | 2011/01/20 | English | 115 |
Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics | 2018/10/02 | English | 114 |
Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics – an update | 2005/02/01 | English | 111 |
Transgenic plants in the biopharmaceutical market | 2005/02/01 | English | 106 |
Liposomal amphotericin B as a treatment for human leishmaniasis | 2012/11/20 | English | 102 |
Adenosine receptor agonists: from basic medicinal chemistry to clinical development | 2003/11/01 | English | 93 |
Emerging drugs for the treatment of anxiety | 2015/05/26 | English | 86 |
Current and emerging pharmacotherapies for treating tobacco dependence | 2006/08/29 | English | 83 |
Emerging Bcl-2 inhibitors for the treatment of cancer | 2010/09/03 | English | 80 |
Emerging drugs for high-grade osteosarcoma | 2010/08/09 | English | 78 |
Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosis | 2006/08/29 | English | 75 |
Emerging drugs to treat squamous cell carcinomas of the head and neck | 2010/06/17 | English | 74 |
Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity | 2012/02/16 | English | 73 |
Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents | 2002/10/01 | English | 72 |
Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors | 2004/05/01 | English | 72 |
Advances in emerging drugs for osteosarcoma | 2015/05/28 | English | 72 |
Emerging adenosine receptor agonists | 2007/09/01 | English | 72 |
Emerging pharmacotherapy of tinnitus | 2009/08/27 | English | 71 |
Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes | 2008/12/01 | English | 71 |
Emerging drugs for Duchenne muscular dystrophy | 2012/05/25 | English | 70 |
Advances in pharmacotherapy for tobacco dependence | 2004/05/01 | English | 70 |
Developments in the treatment of visceral leishmaniasis | 2009/08/27 | English | 67 |
Emerging drugs for osteoarthritis | 2011/05/04 | English | 66 |
Emerging pharmacological strategies in the fight against cocaine addiction | 2006/02/27 | English | 65 |